E89R
TEAS SECTION 8 & 9 RECEIVED
08/13/2026
Back to search
Official data from USPTO
PCI PHARMA SERVICES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PCI PHARMA SERVICES
ST13
US500000087122777Class
39, 40
Filing
87122777
Registration
5165246
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
08/13/2026
Trademark type
Word
Nice classes
39, 40
Filing date
08/01/2016
Registration date
03/21/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/30/2022
Last transaction
08/13/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
10/12/2015
First use in commerce
10/12/2015
Drawing code
4
Owner type
03
Owner location
Philadelphia, PA, US
Examiner
BULLOFF, TOBY ELLEN
Law office
N10
Current location
TMO LAW OFFICE 119
Holders and representatives
Holders
Packaging Coordinators, Inc.
Representatives
Richard E. Peirce Eckert Seamans Cherin & Mellott LLC
Technical classification
Nice Classes
Class 39Class 40
Vienna Codes
No Vienna codes available.
Goods and services
Class 39
Packaging pharmaceutical and health care products to the order and specification of others; logistical services for othersthe storagetransportation and delivery of pharmaceutical products to clinical research trials
Class 40
Manufacturing of pharmaceutical dosage forms for others
Publications
History of USPTO decisions and trademark events.
35 publications found
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
03/21/2026
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
02/12/2025
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
02/28/2024
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
11/30/2022
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11/30/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/30/2022
E815
TEAS SECTION 8 & 15 RECEIVED
05/18/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/21/2022
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
12/16/2020
CORV
REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
06/02/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/19/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/19/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/19/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/19/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/19/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/31/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/31/2020
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
03/31/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/31/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/31/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/31/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
03/21/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/03/2017
PUBO
PUBLISHED FOR OPPOSITION
01/03/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/14/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/14/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
11/14/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/14/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
11/14/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/14/2016
DOCK
ASSIGNED TO EXAMINER
11/11/2016
MPMK
NOTICE OF PSEUDO MARK E-MAILED
08/05/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/04/2016
NWAP
NEW APPLICATION ENTERED
08/04/2016
Continuous trademark protection
Get notified about every new filing that threatens PCI PHARMA SERVICES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.